Pranatharthi H Chandrasekar
Overview
Explore the profile of Pranatharthi H Chandrasekar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1698
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Keri V, Monday L, Ramakrishna J, Vyas R, Deol A, Al-Saadi M, et al.
Transpl Infect Dis
. 2024 Sep;
26(6):e14376.
PMID: 39312203
Background: Chimeric antigen receptor (CAR) T-cell therapy is an emerging therapeutic modality for relapsed and refractory hematological malignancies. Infectious complications following CAR T-cell therapy are not well defined. Methods: This...
2.
Monday L, Keri V, Chandrasekar P
Expert Opin Pharmacother
. 2024 May;
25(6):685-694.
PMID: 38717943
Introduction: Cytomegalovirus (CMV) remains a serious opportunistic infection in hematopoietic cell transplant (HCT) and solid-organ transplant (SOT) recipients. Traditional anti-CMV drugs are limited by toxicities and the development of resistance....
3.
Young J, Andes D, Ardura M, Arrieta A, Bow E, Chandrasekar P, et al.
Open Forum Infect Dis
. 2024 Mar;
11(3):ofae082.
PMID: 38481428
The epidemiology of invasive aspergillosis (IA) is evolving. To define the patient groups who will most likely benefit from primary or secondary prophylaxis, particularly those whose medical conditions and IA...
4.
Keri V, Topulli M, Deol A, Uberti J, Salimnia H, Chandrasekar P
Open Forum Infect Dis
. 2024 Jan;
11(1):ofad633.
PMID: 38288349
Chimeric antigen receptor (CAR) T-cell therapy has emerged as a novel therapeutic option for hematologic malignancies. Human immunodeficiency virus (HIV) nucleic acid amplification tests (NAATs) amplifying 5' long terminal repeat...
5.
Polymerase chain reaction in the diagnosis of invasive aspergillosis: approaches for appropriate use
Keri V, Chandrasekar P
Leuk Lymphoma
. 2023 May;
64(7):1330-1334.
PMID: 37211858
Detection of aspergillus by PCR is a helpful tool for early diagnosis. The test has excellent sensitivity and specificity with a high negative predictive value. Well-accepted, standardized method for DNA...
6.
Maurer S, Linder K, Kauffman C, McDonald P, Arcobello J, Velasco J, et al.
Bone Marrow Transplant
. 2022 Sep;
57(12):1820-1826.
PMID: 36151368
We conducted a retrospective review of the infectious complications and outcomes over a 2-year follow-up period of adult patients who received a second allogeneic hematopoietic cell transplant (2nd allo-HCT) during...
7.
Sivasubramanian G, Chandrasekar P
Expert Opin Pharmacother
. 2022 Jan;
23(5):543-549.
PMID: 35099351
Introduction: Invasive aspergillosis is associated with high morbidity and mortality in immunocompromised patients. It is now increasingly reported in critically ill patients, including those with respiratory viral infections, such as...
8.
Pasula S, Chandrasekar P
Expert Opin Pharmacother
. 2021 Jun;
22(15):2071-2078.
PMID: 34129410
Introduction: Azoles are the first-line antifungal agents used for the treatment of infection. There is an increasing concern for azole resistance all over the world mainly from agricultural fungicide use....
9.
Jarrin Tejada C, Zachariah M, Cruz A, Hussein S, Wipula E, Meeks N, et al.
Clin Transplant
. 2020 Nov;
35(2):e14169.
PMID: 33247978
Transplant recipients are vulnerable to infections, including COVID-19, given their comorbidities and chronic immunosuppression. In this study, all hospitalized renal transplant recipients (RTR) with a positive nasal swab for Severe...
10.
Rottmann B, Singh P, Singh S, Revankar S, Chandrasekar P, Kumar A
Invest Ophthalmol Vis Sci
. 2020 Sep;
61(11):31.
PMID: 32940660
Purpose: Candida remains the leading cause of fungal endophthalmitis. However, the pathobiology and innate immune responses in this disease are not well characterized. Here, we developed two murine models of...